Dr. Reddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 209-524-1211
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1997 - 2000
- University of MichiganResidency, Internal Medicine, 1994 - 1997
- University of California, Irvine, School of MedicineClass of 1994
Certifications & Licensure
- CA State Medical License 1997 - 2026
- NC State Medical License 2020 - 2022
- MI State Medical License 1994 - 1997
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Start of enrollment: 2011 May 01
- A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma Start of enrollment: 2018 Sep 21
Publications & Presentations
PubMed
- 292 citationsNCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand
Journal of the National Comprehensive Cancer Network. 2020-03-01 - 225 citationsManagement of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.John A Thompson, Bryan J Schneider, Julie Brahmer, Amaka Achufusi, Philippe Armand
Journal of the National Comprehensive Cancer Network. 2022-04-01 - 21 citationsLiquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic riskGabriel Velez, Huy V. Nguyen, Teja Chemudupati, Cassie A. Ludwig, Marcus A. Toral
Molecular Cancer. 2021-02-24
Press Mentions
- Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC GuidelinesDecember 12th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: